Thomas Woiwode, Director at CRISPR Therapeutics AG (CRSP), sold 22,841 shares at $51.00 ($1.2M) on 2018-04-24, disclosed to the SEC on 2018-04-26.
Open-market sale of $1.2M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.60 | 589 | $30K | 2.6% |
| 2 | $51.00 | 653 | $33K | 2.9% |
| 3 | $51.00 | 1,528 | $78K | 6.7% |
| 4 | $51.00 | 20,071 | $1.0M | 87.9% |
| Total | $50.99 avg | 22,841 | $1.2M | 100% |
| Filing → |
| ALGS | BUY | 2020-10-20 | $3.0M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-17 | $2.6M | — | Filing → |